The application of nano-biosensors in the detection of 2019-nCoV
Chinese Journal of Laboratory Medicine
; 45(9):987-991, 2022.
Article
in Chinese
| EMBASE | ID: covidwho-2246407
ABSTRACT
The pandemic of 2019 novel coronavirus (2019-nCoV) infection since 2020 caused Coronavirus Disease 2019 (COVID-19) leads the serious threaten to global public health. It is urgent to diagnose COVID-19, guide epidemiological measures, control the infection rates, research/develop the antiviral treatment and promote the vaccine research. The application of nano-material based biosensors (the nano-biosensors) has achieved the high-performance detection of a variety of biomarkers due to their small device size, label free detection, high sensitivity, good specificity, short detection time, and has been considered as great potential to become a point-of-care testing tool for detecting 2019-nCoV. Therefore, by summarizing the working principle and classification of nano-biosensors, and focusing on the research progress of nano-biosensors in the detection of 2019-nCoV reported in the recent years, our review provides the challenges and future development prospects of the nano-biosensor in clinical laboratory.
biosensor; biological marker; vaccine; antiviral therapy; article; clinical laboratory; coronavirus disease 2019; disease surveillance; epidemiological model; genetic procedures; human; infection control; molecular diagnosis; nanotechnology; nonhuman; pandemic; point of care testing; public health; sensitivity and specificity; Severe acute respiratory syndrome coronavirus 2; virus detection
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
Chinese
Journal:
Chinese Journal of Laboratory Medicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS